Clinical Trials Directory

Trials / Unknown

UnknownNCT00223093

TAIZ -Monocytes for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)

A Single-Center Open-Labelled Study of the Administration of Transplant-Acceptance Inducing Cells (TAIZ) for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
10 (planned)
Sponsor
University Hospital Schleswig-Holstein · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Induce tolerance or reduce the amount of immunosuppression after renal transplant patient (receiving cadaver kidney)with so called TAIZ-monocytes

Conditions

Interventions

TypeNameDescription
DRUGTAIZ

Timeline

Start date
2004-02-01
Completion
2005-08-01
First posted
2005-09-22
Last updated
2005-10-28

Source: ClinicalTrials.gov record NCT00223093. Inclusion in this directory is not an endorsement.

TAIZ -Monocytes for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney) (NCT00223093) · Clinical Trials Directory